{"result": {"id": "525be0cc-c4ec-491a-9301-13d04f0d9903", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>AN TUO MING<|>ORGANIZATION<|>An Tuo Ming is a fibrate-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>FENOFIBRATE<|>ORGANIZATION<|>Fenofibrate is a fibrate-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>GEMFIBROZIL<|>ORGANIZATION<|>Gemfibrozil is a fibrate-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>BEZAFIBRATE<|>ORGANIZATION<|>Bezafibrate is a fibrate-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>LOVASTATIN<|>ORGANIZATION<|>Lovastatin is a statin-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>XUE ZHI KANG<|>ORGANIZATION<|>Xue Zhi Kang is a statin-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>SIMVASTATIN<|>ORGANIZATION<|>Simvastatin is a statin-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>PRAVASTATIN<|>ORGANIZATION<|>Pravastatin is a statin-class lipid-lowering drug mentioned in the text)\n##\n(\"entity\"<|>FISH OIL PREPARATIONS<|>ORGANIZATION<|>Fish oil preparations are mentioned as lipid-lowering agents)\n##\n(\"entity\"<|>MAI DONG KANG<|>ORGANIZATION<|>Mai Dong Kang is a fish oil preparation mentioned in the text)\n##\n(\"entity\"<|>POLYENE<|>ORGANIZATION<|>Polyene is mentioned as a lipid-lowering agent)\n##\n(\"entity\"<|>NICOTINIC ACID<|>ORGANIZATION<|>Nicotinic acid is mentioned as a lipid-lowering agent)\n##\n(\"entity\"<|>INOSITOL NICOTINATE<|>ORGANIZATION<|>Inositol nicotinate is mentioned as a lipid-lowering agent)\n##\n(\"entity\"<|>PENTAERYTHRITYL TETRANICOTINATE<|>ORGANIZATION<|>Pentaerythrityl tetranicotinate is mentioned as a lipid-lowering agent)\n##\n(\"entity\"<|>ELASTASE<|>ORGANIZATION<|>Elastase is mentioned as a mild lipid-lowering agent)\n##\n(\"entity\"<|>TERAZOSIN<|>ORGANIZATION<|>Terazosin is mentioned as an alpha-blocker that can affect lipid levels)\n##\n(\"entity\"<|>GINSENG<|>ORGANIZATION<|>Ginseng is mentioned as a traditional Chinese medicine with lipid-lowering effects)\n##\n(\"entity\"<|>GYNOSTEMMA<|>ORGANIZATION<|>Gynostemma is mentioned as a traditional Chinese medicine with lipid-lowering effects)\n##\n(\"entity\"<|>HAWTHORN<|>ORGANIZATION<|>Hawthorn is mentioned as a traditional Chinese medicine with lipid-lowering effects)\n##\n(\"relationship\"<|>AN TUO MING<|>FIBRATE CLASS<|>An Tuo Ming belongs to the fibrate class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>FENOFIBRATE<|>FIBRATE CLASS<|>Fenofibrate belongs to the fibrate class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>GEMFIBROZIL<|>FIBRATE CLASS<|>Gemfibrozil belongs to the fibrate class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>BEZAFIBRATE<|>FIBRATE CLASS<|>Bezafibrate belongs to the fibrate class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>LOVASTATIN<|>STATIN CLASS<|>Lovastatin belongs to the statin class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>XUE ZHI KANG<|>STATIN CLASS<|>Xue Zhi Kang belongs to the statin class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>SIMVASTATIN<|>STATIN CLASS<|>Simvastatin belongs to the statin class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>PRAVASTATIN<|>STATIN CLASS<|>Pravastatin belongs to the statin class of lipid-lowering drugs<|>8)\n##\n(\"relationship\"<|>FISH OIL PREPARATIONS<|>UNSATURATED FATTY ACIDS<|>Fish oil preparations belong to the unsaturated fatty acids class of lipid-lowering agents<|>7)\n##\n(\"relationship\"<|>MAI DONG KANG<|>FISH OIL PREPARATIONS<|>Mai Dong Kang is a type of fish oil preparation<|>9)\n##\n(\"relationship\"<|>POLYENE<|>UNSATURATED FATTY ACIDS<|>Polyene belongs to the unsaturated fatty acids class of lipid-lowering agents<|>7)\n##\n(\"relationship\"<|>NICOTINIC ACID<|>NICOTINIC ACID CLASS<|>Nicotinic acid belongs to the nicotinic acid class of lipid-lowering agents<|>8)\n##\n(\"relationship\"<|>INOSITOL NICOTINATE<|>NICOTINIC ACID CLASS<|>Inositol nicotinate belongs to the nicotinic acid class of lipid-lowering agents<|>8)\n##\n(\"relationship\"<|>PENTAERYTHRITYL TETRANICOTINATE<|>NICOTINIC ACID CLASS<|>Pentaerythrityl tetranicotinate belongs to the nicotinic acid class of lipid-lowering agents<|>8)\n##\n(\"relationship\"<|>ELASTASE<|>ENZYME CLASS<|>Elastase belongs to the enzyme class of lipid-lowering agents<|>7)\n##\n(\"relationship\"<|>TERAZOSIN<|>ALPHA-BLOCKER CLASS<|>Terazosin belongs to the alpha-blocker class of drugs that can affect lipid levels<|>7)\n##\n(\"relationship\"<|>GINSENG<|>TRADITIONAL CHINESE MEDICINE<|>Ginseng is a traditional Chinese medicine with lipid-lowering effects<|>7)\n##\n(\"relationship\"<|>GYNOSTEMMA<|>TRADITIONAL CHINESE MEDICINE<|>Gynostemma is a traditional Chinese medicine with lipid-lowering effects<|>7)\n##\n(\"relationship\"<|>HAWTHORN<|>TRADITIONAL CHINESE MEDICINE<|>Hawthorn is a traditional Chinese medicine with lipid-lowering effects<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166250, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1590, "prompt_tokens": 3125, "total_tokens": 4715, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3072}, "prompt_cache_hit_tokens": 3072, "prompt_cache_miss_tokens": 53}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 良，应适当补充维生素 粤、维生素 运、维生素 阅及钙盐； ②该药不可加大剂量，以免引起胃肠道反应。\n　　（员园）亚油酸摇不良反应有恶心、腹胀、食欲减退、大便次数增 加等，减量或停药后即可消失。\n　　（藻酸双酯钠（多糖硫酸酯、破栓开塞）摇①不良反应可有 发热、白细胞和血小板减少、血压降低、变态反应、肝功能及心电图 异常、头痛、心悸、烦躁、乏力、嗜睡、子宫或结合膜下出血等；②严 重肝、肾功能不全和有出血史者禁用；③禁止静脉注射或肌内 注射。\n　　（员圆）多烯康（脉适宝）摇①该药大剂量可有消化道不适；②该 药可增加乙酰水杨酸和香豆素类药物的抗凝作用；③有出血性疾 病病人禁用。\n摇摇源援使用降血脂药应注意什么\n　　　如果你的血脂检验报告单显示有胆固醇、三酰甘油、低密度脂 蛋白、载脂蛋白 月等指标升高，而高密度脂蛋白、载脂蛋白 粤等降 低，则提示你已存在有动脉硬化和冠心病的易患因素。这时你应 注意调节你的血脂水平。\n　　员）高脂血症病人首先应采取控制饮食、增加运动、减轻体重 等一般性措施。如果无效，才考虑药物治疗。\n圆）合理选用降脂药物：①苯氧乙酸（贝特）类，如安妥明、非诺\n源                                                    \n\n\n\n\n\t 六、高脂血症的治疗         \n　贝特、吉非罗齐、苯扎贝特等，是目前应用最广泛的一类药，它可降 低三酰甘油和低密度脂蛋白，而对高密度脂蛋白则有升高作用。\n②他汀类，如洛伐他丁、血脂康、辛伐他丁、普伐他丁等。对低密度\n　脂蛋白的降低作用比贝特类明显，降三酰甘油和升高密度脂蛋白 的作用则不如贝特类。 ③多不饱和脂肪酸，如鱼油制剂（脉东康、 多烯康等）、亚麻酸等，可降低三酰甘油，但降胆固醇作用较差。 ④烟酸类，如烟酸、烟酸肌醇酯、戊四烟酯等。但部分病人用后有 脸红、心悸、皮肤瘙痒、胃肠道不适等。⑤弹性酶，降脂能力较弱， 但不良反应小，可用于轻度病人。 ⑥α鄄受体阻断剂如特拉哌嗪，可 升高高密度脂蛋白，但易发生体位性低血压。中药人参、绞股蓝、 山楂等也有\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>VITAMIN YUE<|>PERSON<|>Vitamin Yue is mentioned as one of the vitamins that should be supplemented appropriately for health benefits)\n##\n(\"entity\"<|>VITAMIN YUN<|>PERSON<|>Vitamin Yun is mentioned as one of the vitamins that should be supplemented appropriately for health benefits)\n##\n(\"entity\"<|>VITAMIN YUE<|>PERSON<|>Vitamin Yue is mentioned as one of the vitamins that should be supplemented appropriately for health benefits)\n##\n(\"entity\"<|>CALCIUM SALT<|>PERSON<|>Calcium salt is mentioned as one of the supplements that should be taken appropriately for health benefits)\n##\n(\"entity\"<|>LINOLEIC ACID<|>PERSON<|>Linoleic acid is mentioned as a substance with potential adverse effects like nausea, bloating, and decreased appetite)\n##\n(\"entity\"<|>ALGINIC ACID SODIUM<|>PERSON<|>Alginic acid sodium is mentioned as a substance with potential adverse effects like fever, leukopenia, and thrombocytopenia)\n##\n(\"entity\"<|>POLYENE<|>PERSON<|>Polyene is mentioned as a substance that can cause digestive discomfort in large doses and can increase the anticoagulant effect of certain drugs)\n##\n(\"entity\"<|>LIPID-LOWERING DRUGS<|>ORGANIZATION<|>Lipid-lowering drugs are mentioned as a category of medications used to treat high lipid levels, including various classes like fibrates, statins, and unsaturated fatty acids)\n##\n(\"entity\"<|>ARTERIOSCLEROSIS<|>EVENT<|>Arteriosclerosis is mentioned as a condition that can be indicated by certain lipid profile results)\n##\n(\"entity\"<|>CORONARY HEART DISEASE<|>EVENT<|>Coronary heart disease is mentioned as a condition that can be indicated by certain lipid profile results)\n##\n(\"relationship\"<|>VITAMIN YUE<|>CALCIUM SALT<|>Vitamin Yue and calcium salt are both mentioned as supplements that should be taken appropriately for health benefits<|>3)\n##\n(\"relationship\"<|>VITAMIN YUN<|>CALCIUM SALT<|>Vitamin Yun and calcium salt are both mentioned as supplements that should be taken appropriately for health benefits<|>3)\n##\n(\"relationship\"<|>LINOLEIC ACID<|>ALGINIC ACID SODIUM<|>Linoleic acid and alginic acid sodium are both mentioned as substances with potential adverse effects<|>3)\n##\n(\"relationship\"<|>POLYENE<|>LIPID-LOWERING DRUGS<|>Polyene is mentioned as a type of lipid-lowering drug<|>5)\n##\n(\"relationship\"<|>ARTERIOSCLEROSIS<|>CORONARY HEART DISEASE<|>Arteriosclerosis and coronary heart disease are both mentioned as conditions that can be indicated by certain lipid profile results<|>4)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_aa887d5420a7a52747d588b1ce586d5475c137c12be7f44ad1804c9e5aacf51c_v2"}